Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine

Clinical Microbiology and Infection

Volumn 13, Issue 2, 2007, Pages 129-138

  Nikolayevskyy, V V ^a,b   Brown, T J ^a   Bazhora, Y I ^b   Asmolov, A A ^b   Balabanova, Y M ^a   Drobniewski, F A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ODESSA NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

Molecular typing; Mutations; Mycobacterium tuberculosis; Resistance; Typing; Ukraine

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CODON; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PRISON; QUESTIONNAIRE; TUBERCULOSIS; UKRAINE; VARIABLE NUMBER OF TANDEM REPEAT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33846300606     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01583.x     Document Type: Article

References (42)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring project. JAMA 1999; 282: 677-686.
2. Drobniewski F, Atun R, Fedorin I, Bikov A, Coker R. The 'bear trap': The colliding epidemics of tuberculosis and HIV in Russia. Int J STD AIDS 2004; 15: 641-646.
3. Drobniewski F, Nikolayevsky V, Asmolov A, Bazhora Yu, Servetsky S. Increasing trends in HIV and TB rates in Odessa and the Ukraine. Int J STD AIDS 2005; 16: 374-378.
4. Levitska N, Nikolayevsky V, Bazhora Yu, Asmolov O. Drug resistance of Mycobacterium tuberculosis isolates from Nikolaev oblast, Ukraine. Ukrainian Pulmonol J 2003; 4: 17-20 (in Ukrainian).
5. García de Viedma G. Rapid detection of resistance in Mycobacterium tuberculosis: A review discussing molecular approaches. Clin Microbiol Infect 2003; 9: 349-359.
6. Ramaswami S, Musser JM. Molecular genetic basis of antimicrobial resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 1998; 79: 3-29.
7. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992; 358: 591-593.
8. Nikolayevsky V, Brown T, Balabanova Y, Ruddy M, Fedorin I, Drobniewski F. Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara region, Russian Federation. J Clin Microbiol 2004; 42: 4498-4502.
9. Bartfai Z, Somoskovi A, Kodmon C et al. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 2001; 39: 3736-3739.
10. Brown TJ, Herrera-Leon L, Anthony RM, Drobniewski FA. The use of macroarrays for identification of MDR Mycobacterium tuberculosis. J Microbiol Meth 2006; 65: 294-300.
11. Van Rie A, Warren R, Mshanga I et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001; 39: 636-641.
12. Frothingham R, Meeker-O'Connell WA. Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem repeats. Microbiology 1998; 144: 1189-1196.
13. Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol 2001; 39: 3563-3571.
14. Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, Locht C. Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 2000; 36: 762-771.
15. Brudey K, Driscoll J, Rigouts L et al. Mycobacterium tuberculosis complex genetic diversity: Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006; 6: 23.
16. Hewlett D, Franchini D, Horn D et al. Outbreak of multidrug-resistant tuberculosis at a hospital: New York City. Morb Mortal Wkly Rep 1993; 42: 427-433.
17. Barnes P, Cave DM. Molecular epidemiology of tuberculosis. N Engl J Med 2003; 349: 1149-1156.
18. Glynn J, Whiteley J, Bifani P, Kremer K, van Soolingen D. Worldwide occurrence of Beijing strains of Mycobacterium tuberculosis: A systematic review. Emerg Infect Dis 2002; 8: 843-849.
19. Toungoussova O, Mariandyshev A, Bjune G, Sandven P, Caugant D. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel Prison in Russia: Predominance of the W-Beijing clone family. Clin Inf Dis 2003; 37: 665-672.
20. Drobniewski F, Balabanova Y, Nikolayevskyy V et al. Drug-resistant TB, clinical virulence and the dominance of the Beijing strain family in Russia. JAMA 2005; 293: 2726-2731.
21. Qian L, Abe C, Lin T-P et al. rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian Countries. J Clin Microbiol 2002; 40: 1091-1094.
22. Yates M, Drobniewski F, Wilson S. Evaluation of a rapid PCR-based epidemiological typing for routine studies of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 712-714.
23. Kamerbeek J, Schouls L, Kolk A et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914.
24. Kwara A, Schiro R, Cowan L et al. Evaluation of the epidemiologic utility of secondary typing methods for differentiation of Mycobacterium tuberculosis isolates. J Clin Microbiol 2003; 41: 2683-2685.
25. Gibson A, Brown T, Baker L, Drobniewski F. Can 15-locus mycobacterial interspersed repetitive unit-variable-number tandem repeat analysis provide insight into the evolution of Mycobacterium tuberculosis? Appl Environ Microbiol 2005; 71: 8207-8213.
26. Hunter P, Gaston M. Numerical index of the discriminatory ability of typing systems: An application of Simpson's index of diversity. J Clin Microbiol 1988; 26: 2465-2466.
27. Sougakoff W, Rodrigue M, Truffot-Pernot C et al. Use of a high-density DNA probe array for detecting mutations involved in rifampin resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 2004; 10: 289-294.
28. Mokrousov I, Narvskaya O, Limeschenko E, Vyazovaya A, Otten T, Vyshnevskiy B. Analysis of the allelic diversity of the mycobacterial interspersed repetitive units in Mycobacterium tuberculosis strains of the Beijing family: Practical implications and evolutionary considerations. J Clin Microbiol 2004; 42: 2438-2444.
29. Sola C, Filliol I, Legrand E et al. Genotyping of the Mycobacterium tuberculosis complex using MIRUs: Association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect Genet Evol 2003; 3: 125-133.
30. Parsons LM, Salfinger M, Clobridge A et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 2005; 49: 2218-2225.
31. Cheng VCC, Yew WW, Yuen KY. Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis 2005; 24: 711-720.
32. Faustini A, Hall A, Perucci C. Risk factors for multidrug resistant tuberculosis in Europe: A systematic review. Thorax 2006; 61: 158-163.
33. Crudu V, Arnadottir T, Laticevschi D. Resistance to anti-tuberculosis drugs and practices in drug susceptibility testing in Moldova, 1995-99. Int J Tuberc Lung Dis 2003; 7: 336-342.
34. Espinal M. The global situation of MDR-TB. Tuberculosis 2003; 83: 44-51.
35. Cox H, Orozco J, Male R et al. Multidrug-resistant tuberculosis in central Asia. Emerg Infect Dis 2004; 10: 865-872.
36. Fang Z, Doig C, Rayner A, Kenna DT, Watt B, Forbes KJ. Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990-97). J Clin Microbiol 1999; 37: 998-1003.
37. Tracevska T, Jansone I, Baumanis V, Marga O, Lillebaek T. Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2003; 7: 1097-1103.
38. Hilleman D, Kubica T, Rusch-Gerdes S, Niemann S. Disequilibrum in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany. Antimicrob Agents Chemother 2005; 49: 1229-1231.
39. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevsky B. High prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996-2001. Antimicrob Agents Chemother 2002; 46: 1417-1424.
40. Mokrousov I, Bhanu NV, Suffys PN et al. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J Microbiol Meth 2004; 57: 323-335.
41. Mokrousov I, Narvskaya O, Limeschenko E, Otten T, Vyshnevsky B. Novel IS 6110 insertion sites in the direct repeat locus of Mycobacterium tuberculosis clinical strains from the St Petersburg area of Russia and evolutionary and epidemiological considerations. J Clin Microbiol 2002; 40: 1504-1507.
42. Park Y, Shin S, Ryu S et al. Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Meth 2005; 63: 165-172.